Rybak MJ - Search Results

1

Nephrotoxicity of vancomycin, alone and with an aminoglycoside.

Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH. Rybak MJ, et al. J Antimicrob Chemother. 1990 Apr;25(4):679-87. doi: 10.1093/jac/25.4.679. J Antimicrob Chemother. 1990. PMID: 2351627

2

Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia.

Rybak MJ, Bailey EM, Lamp KC, Kaatz GW. Rybak MJ, et al. Antimicrob Agents Chemother. 1992 May;36(5):1109-14. doi: 10.1128/AAC.36.5.1109. Antimicrob Agents Chemother. 1992. PMID: 1324637 Free PMC article. Clinical Trial.

3

CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Lamp KC, Bailey EM, Rybak MJ. Kaatz GW, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1992 Jun;36(6):1192-7. doi: 10.1128/AAC.36.6.1192. Antimicrob Agents Chemother. 1992. PMID: 1329613 Free PMC article.

4

In vitro pharmacodynamic effects of concentration, pH, and growth phase on serum bactericidal activities of daptomycin and vancomycin.

Lamp KC, Rybak MJ, Bailey EM, Kaatz GW. Lamp KC, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1992 Dec;36(12):2709-14. doi: 10.1128/AAC.36.12.2709. Antimicrob Agents Chemother. 1992. PMID: 1336344 Free PMC article.

5

Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.

Rybak MJ, Bailey EM, Warbasse LH. Rybak MJ, et al. Antimicrob Agents Chemother. 1992 Jun;36(6):1204-7. doi: 10.1128/AAC.36.6.1204. Antimicrob Agents Chemother. 1992. PMID: 1384423 Free PMC article. Clinical Trial.

6

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.

McGrath BJ, Bailey EM, Lamp KC, Rybak MJ. McGrath BJ, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1992 Dec;36(12):2741-6. doi: 10.1128/AAC.36.12.2741. Antimicrob Agents Chemother. 1992. PMID: 1482142 Free PMC article.

7

Ofloxacin clinical pharmacokinetics.

Lamp KC, Bailey EM, Rybak MJ. Lamp KC, et al. Among authors: rybak mj. Clin Pharmacokinet. 1992 Jan;22(1):32-46. doi: 10.2165/00003088-199222010-00004. Clin Pharmacokinet. 1992. PMID: 1559306 Review.

8

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.

Rybak MJ, Lerner SA, Levine DP, Albrecht LM, McNeil PL, Thompson GA, Kenny MT, Yuh L. Rybak MJ, et al. Antimicrob Agents Chemother. 1991 Apr;35(4):696-700. doi: 10.1128/AAC.35.4.696. Antimicrob Agents Chemother. 1991. PMID: 1829880 Free PMC article.

9

Comparative effect of protein binding on the killing activities of teicoplanin and vancomycin.

Bailey EM, Rybak MJ, Kaatz GW. Bailey EM, et al. Among authors: rybak mj. Antimicrob Agents Chemother. 1991 Jun;35(6):1089-92. doi: 10.1128/AAC.35.6.1089. Antimicrob Agents Chemother. 1991. PMID: 1834010 Free PMC article. Clinical Trial.

10

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

Rybak MJ, Bailey EM, Reddy VN. Rybak MJ, et al. Antimicrob Agents Chemother. 1991 Aug;35(8):1586-90. doi: 10.1128/AAC.35.8.1586. Antimicrob Agents Chemother. 1991. PMID: 1834014 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results